Plerixafor (rINN and USAN, trade name Mozobil) is an immunostimulant used to mobilize hematopoietic stem cells in cancer patients. The stem cells are subsequently transplanted back to the patient. The drug was developed by AnorMED which was subsequently bought by Genzyme.

Read more about Plerixafor:  History, Indications, Adverse Effects, Chemical Properties, Pharmacokinetics, Pharmacodynamics, Interactions, Legal Status

Other articles related to "plerixafor":

Plerixafor - Research - Other Uses
... Blockade of CXCR4 signalling by plerixafor (AMD3100) has also unexpectedly been found to be effective at counteracting opioid-induced hyperalgesia produced by chronic treatment with morphine ...